SAP's Buyback Nears 9.6 Million Shares as AstraZeneca Joins Cloud ERP Private
Published on 11/15/2026 at 04:01 | Editorial boerse-global.de
SAP's share repurchase programme has now accumulated roughly 9.6 million shares, the Walldorf-based software group reported, after picking up about 465,000 of its own stock on Xetra during the buyback week that ended 6 November. The disclosure, published on Tuesday, keeps investors abreast of a programme that has been running steadily in the background while more headline-grabbing news swirls around the company.
AstraZeneca Extends a 20-Year Alliance
Among the week's commercial developments, SAP confirmed that AstraZeneca is migrating to SAP Cloud ERP Private as part of RISE with SAP. The move extends a partnership between the two companies that stretches back two decades. The pharmaceutical giant's shift to the private cloud edition marks one of the more prominent endorsements of SAP's cloud strategy in the life sciences sector.
SAP also released product-related emissions and energy data for customers of its cloud offerings. According to the company, the figures show the consumption of supported SAP cloud products based on the infrastructure each customer uses — a disclosure that speaks to growing corporate demand for transparency around the environmental footprint of enterprise software.
Security Patch Day Brings 35 Notes
Tuesday's November Security Patch Day saw SAP publish 35 new security notes alongside four GitHub Security Advisories. The company also flagged critical vulnerabilities among the fixes, meaning the release addressed some of the more serious security issues affecting its products.
Should investors sell immediately? Or is it worth buying SAP?
Separately, supervisory board member Qi Lu stepped down with immediate effect on Wednesday, citing personal reasons. Handelsblatt reported that the departure is likely connected to US sanctions targeting his venture capital fund, Miracle Plus.
JPMorgan Doubles Down on the AI Thesis
The most closely watched item of the week came from JPMorgan, which upgraded SAP from "Neutral" to "Overweight" and lifted its price target from 175 to 275 euros. Analyst Toby Ogg anchored the call on enterprise AI moving out of the pilot phase and into productive use, together with progress on SAP's own AI offerings. The recommendation gave the stock a positive nudge on the day it landed, with shares rising 0.8% to €213.20 in Friday trading.
CFO Takes the Road
Investor engagement is set to pick up in the coming weeks. CFO Dominik Asam is scheduled to appear at the Morgan Stanley TMT Conference in Barcelona on 19 November 2026, followed by the UBS Global Technology Conference in Scottsdale on 1 December 2026.
SAP at a turning point? This analysis reveals what investors need to know now.
On the earnings calendar, SAP's next scheduled release is preliminary figures for the fourth quarter and full-year 2026, due on 28 January 2027.
Ad
SAP Stock: New Analysis - 15 November
Fresh SAP information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
